Clinical evidence for Japanese population based on prospective studies-Linking clinical trials and clinical practice

Journal of Cardiology

Volumn 54, Issue 2, 2009, Pages 171-182

  Ogawa, Hisao ^a   Kojima, Sunao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Diabetes mellitus; Evidence; Evidence based medicine; Myocardial infarction; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTITHROMBOCYTIC AGENT; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; CALVEDILOL; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANIDIPINE; METOPROLOL; NIFEDIPINE; NISOLDIPINE; PITAVASTATIN; PRAVASTATIN; SIMVASTATIN; TRAPIDIL; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CLINICAL TRIAL; DIABETES MELLITUS; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; JAPANESE; LIPID BLOOD LEVEL; LOW DRUG DOSE; POPULATION RESEARCH; PRACTICE GUIDELINE; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ASPIRIN; ATHEROSCLEROSIS; CALCIUM CHANNEL BLOCKERS; DIABETES COMPLICATIONS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; JAPAN; MALE; MULTICENTER STUDIES AS TOPIC; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRAPIDIL;

EID: 70349289114     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.05.001     Document Type: Review

References (26)

1. Menotti A., Puddu P.E., Lanti M., Kromhout D., Blackburn H., and Nissinen A. Twenty-five-year coronary mortality trends in the seven countries study using the accelerated failure time model. Eur J Epidemiol 18 (2003) 113-122
2. Sohn D.R., Shin S.G., Park C.W., Kusaka M., Chiba K., and Ishizaki T. Metoprolol oxidation polymorphism in a Korean population: comparison with native Japanese and Chinese populations. Br J Clin Pharmacol 32 (1991) 504-507
3. Wood A.J. Racial differences in the response to drugs-pointers to genetic differences. N Engl J Med 344 (2001) 1394-1396
4. Beta-Blocker Evaluation of Survival Trial Investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 344 (2001) 1659-1667
5. Yasue H., Ogawa H., Tanaka H., Miyazaki S., Hattori R., Saito M., Ishikawa K., Masuda Y., Yamaguchi T., Motomiya T., and Tamura Y. Effects of aspirin and trapidil on cardiovascular events after acute myocardial infarction. Japanese Antiplatelets Myocardial Infarction Study (JAMIS) Investigators. Am J Cardiol 83 (1999) 1308-1313
6. Japanese Beta-Blockers, Calcium Antagonists Myocardial Infarction (JBCMI) Investigators. Comparison of the effects of beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects. Am J Cardiol 93 (2004) 969-973
7. Sakamoto T., Kojima S., Ogawa H., Shimomura H., Kimura K., Ogata Y., Sakaino N., and Kitagawa A. Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese. Am J Cardiol 97 (2006) 1165-1171
8. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
9. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S., Kojima Y., Furuyoshi N., and Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28 (1995) 103-117
10. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
11. Ogawa H., Nakayama M., Morimoto T., Uemura S., Kanauchi M., Doi N., Jinnouchi H., Sugiyama S., and Saito Y. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA 300 (2008) 2134-2141
12. Farkouh M.E., and Fuster V. Diabetes and aspirin: beware of underpowered negative trials. Nat Clin Pract Cardiovasc Med 6 (2009) 1
13. Kojima S., Sakamoto T., Kitagawa A., and Ogawa H. MUSASHI investigators. Standard-dose statin therapy demonstrates additional effects in diabetic patients with normal cholesterol levels. Circulation 116 16 Suppl. (2007) II_855-6
14. Kosuge M., Kimura K., Kojima S., Sakamoto T., Ishihara M., Asada Y., Tei C., Miyazaki S., Sonoda M., Tsuchihashi K., Yamagishi M., Ikeda Y., Shirai M., Hiraoka H., Inoue T., et al. Effects of preinfarction angina pectoris on infarct size and in-hospital mortality after coronary intervention for acute myocardial infarction. Am J Cardiol 92 (2003) 840-843
15. Kojima S., Sakamoto T., Ishihara M., Kimura K., Miyazaki S., Tei C., Hiraoka H., Sonoda M., Tsuchihashi K., Yamagishi M., Inoue T., Asada Y., Ikeda Y., Shirai M., and Ogawa H. The white blood cell count is an independent predictor of no-reflow and mortality following acute myocardial infarction in the coronary interventional era. Ann Med 36 (2004) 153-160
16. Kosuge M., Kimura K., Kojima S., Sakamoto T., Matsui K., Ishihara M., Asada Y., Tei C., Miyazaki S., Sonoda M., Tsuchihashi K., Yamagishi M., Ikeda Y., Shirai M., Hiraoka H., et al. Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. Circ J 69 (2005) 375-379
17. Kojima S., Sakamoto T., Ishihara M., Kimura K., Miyazaki S., Yamagishi M., Tei C., Hiraoka H., Sonoda M., Tsuchihashi K., Shimoyama N., Honda T., Ogata Y., Matsui K., and Ogawa H. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol 96 (2005) 489-495
18. Kosuge M., Kimura K., Kojima S., Sakamoto T., Ishihara M., Asada Y., Tei C., Miyazaki S., Sonoda M., Tsuchihashi K., Yamagishi M., Ikeda Y., Shirai M., Hiraoka H., Inoue T., et al. Beneficial effect of preinfarction angina on in-hospital outcome is preserved in elderly patients undergoing coronary intervention for anterior acute myocardial infarction. Circ J 69 (2005) 630-635
19. Ishihara M., Kojima S., Sakamoto T., Asada Y., Tei C., Kimura K., Miyazaki S., Sonoda M., Tsuchihashi K., Yamagishi M., Ikeda Y., Shirai M., Hiraoka H., Inoue T., Saito F., et al. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 150 (2005) 814-820
20. Kosuge M., Kimura K., Kojima S., Sakamoto T., Ishihara M., Asada Y., Tei C., Miyazaki S., Sonoda M., Tsuchihashi K., Yamagishi M., Ikeda Y., Shirai M., Hiraoka H., Inoue T., et al. Sex differences in early mortality of patients undergoing primary stenting for acute myocardial infarction. Circ J 70 (2006) 217-221
21. Kawano H., Soejima H., Kojima S., Kitagawa A., and Ogawa H. Sex differences of risk factors for acute myocardial infarction in Japanese patients. Circ J 70 (2006) 513-517
22. Ishihara M., Kojima S., Sakamoto T., Asada Y., Kimura K., Miyazaki S., Yamagishi M., Tei C., Hiraoka H., Sonoda M., Tsuchihashi K., Shinoyama N., Honda T., Ogata Y., and Ogawa H. Usefulness of combined white blood cell count and plasma glucose for predicting in-hospital outcomes after acute myocardial infarction. Am J Cardiol 97 (2006) 1558-1563
23. Kojima S., Matsui K., Sakamoto T., Ishihara M., Kimura K., Miyazaki S., Yamagishi M., Tei C., Hiraoka H., Sonoda M., Tsuchihashi K., Shimoyama N., Honda T., Ogata Y., and Ogawa H. Long-term nitrate therapy after acute myocardial infarction does not improve or aggravate prognosis. Circ J 71 (2007) 301-307
24. Matsui K., Kojima S., Sakamoto T., Ishihara M., Kimura K., Miyazaki S., Yamagishi M., Tei C., Hiraoka H., Sonoda M., Tsuchihashi K., Ooie T., Honda T., Ogata Y., and Ogawa H. Weekend onset of acute myocardial infarction does not have a negative impact on outcome in Japan. Circ J 71 (2007) 1841-1844
25. Kosuge M., Kimura K., Kojima S., Sakamoto T., Ishihara M., Asada Y., Tei C., Miyazaki S., Sonoda M., Tsuchihashi K., Yamagishi M., Shirai M., Hiraoka H., Honda T., Ogata Y., et al. Impact of body mass index on in-hospital outcomes after percutaneous coronary intervention for ST segment elevation acute myocardial infarction. Circ J 72 (2008) 521-525
26. Kosuge M., Kimura K., Morita S., Kojima S., Sakamoto T., Ishihara M., Asada Y., Tei C., Miyazaki S., Sonoda M., Tsuchihashi K., Yamagishi M., Shirai M., Hiraoka H., Honda T., et al. Combined prognostic utility of white blood cell count, plasma glucose, and glomerular filtration rate in patients undergoing primary stent placement for acute myocardial infarction. Am J Cardiol 103 (2009) 322-327